Whole human genome sequences could soon cost as little as $1,000, but Cold Spring Harbor Laboratory's Gholson Lyon says that "the current biomedical research establishment is entirely unprepared for such a scenario." Here's why: "Researchers often believe that their mission is to uncover new biology and genetics, and that someone else will translate them to the clinical arena," he writes in a post at Project Syndicate.